These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29514406)

  • 1. Liver transplantation for intrahepatic cholangiocarcinoma.
    Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
    Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience.
    Elshamy M; Presser N; Hammad AY; Firl DJ; Coppa C; Fung J; Aucejo FN
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):264-270. PubMed ID: 28603094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
    Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.
    Antwi SO; Habboush YY; Chase LA; Lee DD; Patel T
    Ann Hepatol; 2018 Oct; 17(6):969-979. PubMed ID: 30600299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
    Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
    HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of liver transplantation for cholangiocarcinoma.
    Goldaracena N; Gorgen A; Sapisochin G
    Liver Transpl; 2018 Feb; 24(2):294-303. PubMed ID: 29024405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors.
    Dageforde LA; Vachharajani N; Tabrizian P; Agopian V; Halazun K; Maynard E; Croome K; Nagorney D; Hong JC; Lee D; Ferrone C; Baker E; Jarnagin W; Hemming A; Schnickel G; Kimura S; Busuttil R; Lindemann J; Florman S; Holzner ML; Srouji R; Najjar M; Yohanathan L; Cheng J; Amin H; Rickert CA; Yang JD; Kim J; Pasko J; Chapman WC; Majella Doyle MB
    J Am Coll Surg; 2021 Apr; 232(4):361-371. PubMed ID: 33316425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
    Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatic tumors: a systematic review.
    Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
    World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.
    Vilchez V; Shah MB; Daily MF; Pena L; Tzeng CW; Davenport D; Hosein PJ; Gedaly R; Maynard E
    HPB (Oxford); 2016 Jan; 18(1):29-34. PubMed ID: 26776848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma.
    Panjala C; Senecal DL; Bridges MD; Kim GP; Nakhleh RE; Nguyen JH; Harnois DM
    Am J Transplant; 2010 May; 10(5):1263-7. PubMed ID: 20420633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
    Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis.
    De Martin E; Rayar M; Golse N; Dupeux M; Gelli M; Gnemmi V; Allard MA; Cherqui D; Sa Cunha A; Adam R; Coilly A; Antonini TM; Guettier C; Samuel D; Boudjema K; Boleslawski E; Vibert E
    Liver Transpl; 2020 Jun; 26(6):785-798. PubMed ID: 32090444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.